Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

larotaxel

A semi-synthetic derivative of the taxane 10-deacetylbaccatin III with potential antineoplastic activities. Larotaxel binds to tubulin, promoting… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Nanoscopy compatible fluorescent tubulin probes can be used to stain microtubules and chitin-rich taenidia in the insect… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Combination chemotherapy with gemcitabine and cisplatin in patients with metastatic urothelial cancer of the bladder frequently… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
PurposeLarotaxel is a new taxane compound with poor solubility. The aim of this study is to develop a new formulation to locate… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2012
2012
AbstractA UPLC-ESI-MS/MS method has been developed and validated for the determination of larotaxel in beagle dog plasma. After… Expand
  • figure 2
  • figure 3
  • table 1
  • table 2
  • figure 4
Is this relevant?
2011
2011
The isolation and characterization of the process related impurities and degradation products of larotaxel drug substance were… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Review
2009
Review
2009
Significant advances in cancer treatment have been achieved with novel targeted and state-of-the-art treatments. While the… Expand
Is this relevant?
2009
2009
Larotaxel (XRP9881, RPR109881), a novel semi-synthetic taxoid that shares a mode of action with the taxanes docetaxel and… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
  • U. Vaishampayan
  • Current treatment options in oncology
  • 2009
  • Corpus ID: 21481179
Opinion statementAdvanced bladder/urothelial cancer remains an incurable terminal disease, and accounts for 3% of the cancer… Expand
Is this relevant?
2008
2008
Introduction: This randomized phase II study investigated the efficacy and safety of a new taxane, larotaxel (XRP9881), in… Expand
Is this relevant?
2008
2008
1070 Background: Larotaxel (L), a semi-synthetic taxoid, has shown preclinical and clinical activity against taxane-resistant BC… Expand
Is this relevant?